Oral glucose tolerance test significantly impacts the prevalence of abnormal glucose tolerance among Indian women with polycystic ovary syndrome Lessons from a large database of two tertiary care centers on the Indian subcontinent

Tuesday, December 29, 2015
Indian women with polycystic ovary syndrome (PCOS) have a high prevalence of abnormal glucose tolerance, and oral glucose tolerance test significantly impacts its prevalence. Data are from a large cohort of women with PCOS attending two tertiary care centers in north India.

Read More

Ovarian volume in normal and hyperandrogenic adolescent women

Monday, June 29, 2015
After the first 2 years from menarche, the threshold for increased ovarian size is similar to that reported in adult women.

Read More

Ultrasound features of polycystic ovaries relate to degree of reproductive and metabolic disturbance in polycystic ovary syndrome

Friday, February 27, 2015
Associations between ultrasound features and reproductive and metabolic markers in women with polycystic ovary syndrome (PCOS) were assessed. Follicle populations reflected the severity of reproductive and metabolic dysfunction in PCOS.

Read More

Inflammatory biomarkers and telomere length in women with polycystic ovary syndrome

Friday, January 30, 2015
Leukocyte telomere length (LTL) did not differ between PCOS and control groups; however, C-reactive protein and homocysteine were negatively correlated with LTL in the PCOS group.

Read More

Dietary glycemic index is associated with less favorable anthropometric and metabolic profiles women with different phenotypes

Monday, September 30, 2013
Dietary glycemic index is increased in the classic polycystic ovary syndrome (PCOS) phenotype and associated with less favorable anthropometric and metabolic profiles. Obesity and classic PCOS phenotype are predictors of higher dietary glycemic index.

Read More

Hepatotoxicity with low and ultralow dose flutamide A surveillance study on 203 hyperandrogenic young females

Thursday, September 27, 2012
Hepatotoxicity is a rare but possible event when using low- and ultralow-dose regimens of flutamide for hyperandrogenic treatment. We need larger studies in order to identify risk patterns for hepatotoxicity development.

Read More

Comparative study of the therapeutic effects of oral contraceptive pills containing desogestrel cyproterone acetate and drospirenone in patients with polycystic ovary syndrome

Thursday, September 27, 2012
Therapeutic effects of three different oral contraceptive pills are comparable after 6 months of treatment. After 12 months, the cyproterone containing pill shows greater antiandrogenic effect. Effects on metabolic parameters are identical.

Read More

Translate »